Peter Hafkemeyer
Impact in
Papers in
-
- HIV/AIDS drug development and treatment 11
-
- Hepatitis B Virus Studies 6
- Co-authors
- Saibal Dey (3 shared papers)Michael M. Gottesman (4 shared papers)Ulrich Hübscher (5 shared papers)Elena Ferrari (2 shared papers)Thomas Weiser (1 shared paper)Max Gassmann (1 shared paper)Pia Thömmes (1 shared paper)Hubert E. Blum (6 shared papers)
- Journals
- Biochemistry (2 papers)Hepatology (2 papers)Human Gene Therapy (2 papers)Journal of Biological Chemistry (2 papers)Gastroenterology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Peter Hafkemeyer
22 papers receiving 612 citations
Peers
Comparison fields: 5 of 68
- Oncology 254
- Virology 42
- Infectious Diseases 142
- Hepatology 55
- Pediatrics, Perinatology and Child Health 86
Countries citing papers authored by Peter Hafkemeyer
This map shows the geographic impact of Peter Hafkemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hafkemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hafkemeyer more than expected).
Fields of papers citing papers by Peter Hafkemeyer
This network shows the impact of papers produced by Peter Hafkemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hafkemeyer. The network helps show where Peter Hafkemeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hafkemeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 133 | |
| 2 | 2003 | 82 | |
| 3 | 1998 | 69 | |
| 4 | 1999 | 49 | |
| 5 | 2007 | 43 | |
| 6 | 2002 | 39 | |
| 7 | 1994 | 32 | |
| 8 | 1994 | 24 | |
| 9 | 1998 | 23 | |
| 10 | 2009 | 22 | |
| 11 | 1991 | 21 | |
| 12 | 1999 | 20 | |
| 13 | 2000 | 16 | |
| 14 | 1996 | 15 | |
| 15 | 1991 | 11 | |
| 16 | 2000 | 11 | |
| 17 | 2001 | 10 | |
| 18 | Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo. | 1996 | 5 |
| 19 | 1998 | 4 | |
| 20 | HIV-reverse transcriptase and human DNA polymerase alpha share amino acid sequence homologies to bacterial penicillin-binding proteins. | 1990 | 4 |
About Peter Hafkemeyer
Peter Hafkemeyer is a scholar working on Infectious Diseases, Epidemiology, Oncology, Molecular Biology and Virology, having authored 23 papers that have together received 639 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (6 papers), Drug Transport and Resistance Mechanisms (6 papers), HIV Research and Treatment (4 papers), Hepatitis C virus research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Oncology (254 citations), Virology (42 citations), Infectious Diseases (142 citations), Hepatology (55 citations) and Pediatrics, Perinatology and Child Health (86 citations). Peter Hafkemeyer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Saibal Dey, Michael M. Gottesman, Ulrich Hübscher, Elena Ferrari, Thomas Weiser, Max Gassmann, Pia Thömmes, Hubert E. Blum, Ira Pastan and Christine A. Hrycyna. Their work appears in journals such as Biochemistry, Hepatology, Human Gene Therapy, Journal of Biological Chemistry and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.